The United States Patent and Trademark Office (USPTO) launched a new COVID-19 Response Resource Center as a central access point for all USPTO initiatives relating to disruptions caused by COVID-19. Some of these initiatives featured on the COVID-19 Response Resource Center include:
- Patents 4 Partnerships—An intellectual property marketplace focused on facilitating licensing opportunities.
The IP Marketplace Platform features a listing of patents and patent application publications indicated as “available for licensing”. The initial release of the IP Marketplace Platform focuses on technologies related to the prevention, diagnosis, and treatment of COVID-19 in view of the current public health situation. Examples of such technologies include disinfectants, testing equipment, personal protective equipment, and components of these technologies.
- COVID-19 Prioritized Examination Pilot Program—A new prioritized examination platform for inventions relating to the diagnosis, prevention, or treatment of COVID-19.
In order to participate in the program, applications must contain one or more claims to a product or process related to COVID-19. In addition, the product or process must be subject to FDA approval. Types of patents encompassed by the pilot program include non-continuing, original, nonprovisional utility or plant patent applications filed with an acceptable request to participate.
- COVID-19 Prioritized Trademark and Service Mark Application program—To be eligible for prioritized examination, an applicant must be seeking registration for the following:
“…pharmaceutical products or medical devices such as diagnostic tests, ventilators, and personal protective equipment, including surgical masks, face shields, gowns, and gloves that prevent, diagnose, treat, or cure COVID-19 and are subject to approval by the United States Food and Drug Administration”.
–June 12, 2020 Trademark and Service Mark Notice